Messa C, Volonté M A, Fazio F, Zito F, Carpinelli A, d'Amico A, Rizzo G, Moresco R M, Paulesu E, Franceschi M, Lucignani G
INB-CNR, University of Milan, H San Raffaele Institute of Milan, Italy.
Eur J Nucl Med. 1998 Sep;25(9):1270-6. doi: 10.1007/s002590050295.
Functional imaging of the presynaptic dopaminergic activity using single-photon emission tomography (SPET) and iodine-123 labelled 2-beta-carboxymethoxy-3-beta-(4-iodophenyl)tropane ([123I]beta-CIT) is important for the assessment of disease severity and progression in patients with Parkinson's disease (PD). However, its capability to discriminate between different extrapyramidal disorders has not yet been assessed. The aim of this study was to evaluate the possibility of differentiating patients with PD and with progressive supranuclear palsy (PSP) by means of this method. The distribution of [123I]beta-CIT in the basal ganglia was assessed in six normal subjects, 13 petients with PD and five patients with PSP in whom the disease was mild. SPET images were obtained 24+/-2 h after i.v. injection of the tracer using a brain-dedicated system (CERASPECT). MR and SPET images were co-registered in four normal subjects and used to define a standard set of 16 circular regions of interest (ROIs) on the slice showing the highest striatal activity. The basal ganglia ROIs corresponded to (1) the head of caudate, (2) a region of transition between the head of caudate and the anterior putamen, (3) the anterior putamen and (4) the posterior putamen. A ratio of specific to non-displaceable striatal uptake was calculated normalising the activity of the basal ganglia ROIs to that of the occipital cortex (V3"). ANOVA revealed a global reduction of V3" in all ROIs of PD and PSP patients compared with normal controls (P<0. 0001). A Mann-Whitney U test showed that the difference between PD and PSP patients was statistically significant for the caudate region only (Z value: 2.6; P<0.01). By subtracting V3" caudate values from those of the putamen, differentiation from PSP was possible in 10/13 PD patients. In conclusion, analysis of [123I]beta-CIT distribution in discrete striatal areas provides information on the relative caudate-putamen damage, with different values being obtained in patients clinically diagnosed as having either PD or PSP.
使用单光子发射断层扫描(SPET)和碘 - 123标记的2 - β - 羧甲氧基 - 3 - β - (4 - 碘苯基)托烷([123I]β - CIT)对突触前多巴胺能活性进行功能成像,对于评估帕金森病(PD)患者的疾病严重程度和进展具有重要意义。然而,其区分不同锥体外系疾病的能力尚未得到评估。本研究的目的是通过这种方法评估区分PD患者和进行性核上性麻痹(PSP)患者的可能性。在6名正常受试者、13名PD患者和5名病情较轻的PSP患者中评估了[123I]β - CIT在基底神经节的分布。在静脉注射示踪剂后24±2小时,使用脑专用系统(CERASPECT)获得SPET图像。在4名正常受试者中对MR和SPET图像进行了配准,并用于在显示最高纹状体活性的切片上定义一组16个圆形感兴趣区域(ROI)的标准集。基底神经节ROI对应于(1)尾状核头部,(2)尾状核头部与前壳核之间的过渡区域,(3)前壳核和(4)后壳核。通过将基底神经节ROI的活性与枕叶皮质(V3”)的活性进行归一化,计算出特异性与不可置换纹状体摄取的比率。方差分析显示,与正常对照组相比,PD和PSP患者所有ROI中的V3”均出现整体降低(P < 0.0001)。曼 - 惠特尼U检验表明,仅尾状核区域的PD和PSP患者之间的差异具有统计学意义(Z值:2.6;P < 0.01)。通过从壳核的V3”尾状核值中减去壳核的值,13名PD患者中有10名能够与PSP区分开来。总之,分析离散纹状体区域中[123I]β - CIT的分布可提供有关尾状核 - 壳核相对损伤的信息,临床诊断为PD或PSP的患者可获得不同的值。